
Top 5 Infectious Disease News Stories Week of May 10 to May 17
A phase 3b trial presented at Digestive Disease Week 2025 showed that colonoscopic administration of fecal microbiota live-jslm (Rebyota or RBL) is a safe and effective method for preventing recurrent Clostridioides difficile infection in adults. In the …